Phaxiam Therapeutics SA (PHXM)

Not featured in screeners

Not featured in screeners

Ticker: PHXM Exchange: PAR

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

Guy Rigaud

Censeur

1 purchase — total 43,822 EUR

Buy 23 Jun 2023

Value €3,730,469.12 | Price 311.22 | Shares 55,908

GO CAPITAL SAS

Administrateur

1 purchase — total 2,255,495 EUR

Buy 23 Jun 2023

Value €2,601,626.17 | Price 412.47 | Shares 75,884

Thibaut du Fayet

Directeur général

1 purchase — total 33,466 EUR

Buy 23 Jun 2023

Value €33,465.82 | Price 0.61 | Shares 54,862

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-07-06	2023-06-23	B Purchase	1.9 Guy Rigaud Censeur	55,908 311.22 €3,730,469	55,908	311.22	€3,730,469
2023-07-04	2023-06-23	B Purchase	GO CAPITAL SAS Administrateur Director	75,884 412.47 €2,601,626	75,884	412.47	€2,601,626
2023-07-04	2023-06-23	B Purchase	Thibaut du Fayet Directeur général Officer	46,894 120.27 €1,207,505	46,894	120.27	€1,207,505

More insider trading research around Phaxiam Therapeutics SA